177LU QUALITY ANALYSIS FOR AN EFFICIENT PREPARATION OF 177LU-LABELED COMPOUNDS.

被引：0
|
作者：
Zhernosekov, K. [1 ,2 ]
Geistlich, S. [1 ]
Blanc, A. [1 ]
Landolt, S. [1 ]
Turler, A. [1 ,3 ]
Schibli, R. [1 ]
机构：
[1] PSI, Lab Radiochem & Environm Chem, Villigen, Switzerland
[2] ETH PSI USZ, Ctr Radiopharmaceut Sci, Villigen, Switzerland
[3] Bern Univ, Dept Chem & Biochem, Bern, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2012年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
270
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [1] Comparative cytotoxicity of 177Lu on various lung cancer cells and in vivo targeting of 177Lu-labeled cetuximab
    Li, Kehong
    Fan, Wenqi
    Yan, Jingxuan
    Wang, Jing
    Zhao, Peng
    Liao, Wei
    Yang, Yuchuan
    Yang, Xia
    Wei, Hongyuan
    Chen, Yue
    [J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2023, 332 (06) : 2093 - 2102
  • [2] Comparative cytotoxicity of 177Lu on various lung cancer cells and in vivo targeting of 177Lu-labeled cetuximab
    Kehong Li
    Wenqi Fan
    Jingxuan Yan
    Jing Wang
    Peng Zhao
    Wei Liao
    Yuchuan Yang
    Xia Yang
    Hongyuan Wei
    Yue Chen
    [J]. Journal of Radioanalytical and Nuclear Chemistry, 2023, 332 : 2093 - 2102
  • [3] On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor
    Das, Tapas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Venkatesh, Meera
    [J]. APPLIED RADIATION AND ISOTOPES, 2007, 65 (03) : 301 - 308
  • [4] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Nanabala, Raviteja
    Pillai, Maroor Raghavan Ambikalmajan
    Gopal, Buvaneswari
    [J]. NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (06) : 313 - 322
  • [5] Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu-labeled PSMA inhibitor
    Chakraborty, Sudipta
    Chakravarty, Rubel
    Shetty, Priyalata
    Vimalnath, K. V.
    Sen, Ishita B.
    Dash, Ashutosh
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (09): : 364 - 371
  • [6] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Raviteja Nanabala
    Maroor Raghavan Ambikalmajan Pillai
    Buvaneswari Gopal
    [J]. Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
  • [7] Quality Control Testing of 177Lu
    Lynch, W.
    Mayer, P.
    Murray, L.
    Ladderbush, D.
    Cutler, C.
    Ketring, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S208 - S208
  • [8] 177Lu-DOTATATE: comparative study between 177Lu NRG/Netherlands and 177Lu ORNL/USA
    Caldeira Filho, Jose de Souza
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 691 - 692
  • [9] Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects
    Chakraborty, Avik
    Mitra, Arpit
    Sahu, Sudeep
    Tawate, Megha
    Lad, Sangita
    Kamaldeep
    Rakshit, Sutapa
    Bannore, Trupti Upadhye
    Gaikwad, Sujay
    Dhotre, Geetanjali
    Ray, Mukti Kanta
    Damle, Archana
    Basu, Sandip
    Banerjee, Sharmila
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2024, 26 (01) : 61 - 80
  • [10] Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects
    Avik Chakraborty
    Arpit Mitra
    Sudeep Sahu
    Megha Tawate
    Sangita Lad
    Sutapa Kamaldeep
    Trupti Rakshit
    Sujay Upadhye Bannore
    Geetanjali Gaikwad
    Mukti Kanta Dhotre
    Archana Ray
    Sandip Damle
    Sharmila Basu
    [J]. Molecular Imaging and Biology, 2024, 26 : 61 - 80
12345